1.Design of broadband power divider in microwave hyperthermia system.
Bing SUN ; Guotai JIANG ; Xiaofeng LU ; Yi CAO
Journal of Biomedical Engineering 2010;27(5):974-977
In clinical application of microwave hyperthermia, multi-applicators are often simultaneously required to irradiate the tumor because of its large volume or its deep location. Power divider separates the input microwave energy into equal, or unequal, energy to each applicator. In this paper, the design procedure for the three-section transmission-line transformer based one-to-two equal-split Wilkinson power divider is introduced. By impedance analysis on equivalent scheme, the design parameter of power divider is provided, and by simulation and optimization on Ansoft HFSS, a microstrip structure Wilkinson power divider operating frequency 2. 45 GHz is given. Measurement test results from network analyzer show that it has 25% bandwidth and good isolation in output with this structure. Besides, it is characterized by small size and easy processing. This power divider suits microwave hyperthermia.
Electric Impedance
;
Electromagnetic Phenomena
;
Equipment Design
;
Humans
;
Hyperthermia, Induced
;
instrumentation
;
Microwaves
;
Neoplasms
;
therapy
2.Role of ubiquitin-specific proteases in hepatocellular carcinoma
Yi TANG ; Guotai WANG ; Yuhan JIANG
Journal of Clinical Hepatology 2025;41(5):968-974
Hepatocellular carcinoma (HCC) is a common primary malignant tumor. In recent years, the role of ubiquitin-specific proteases (USPs) in HCC has attracted widespread attention. USPs are a class of key deubiquitinating enzymes that affect a variety of biological processes by regulating the ubiquitination status of proteins. Studies have shown that USPs participate in the regulation of cell proliferation, apoptosis, migration, and invasion by deubiquitinating various tumor-related proteins. In addition, the abnormal expression of USPs is closely associated with the prognosis of HCC patients and may thus be used as potential biomarkers and therapeutic targets. This article reviews the research advances in USPs in HCC and explores their key roles in the development, progression, and metastasis of HCC. A deep understanding of the mechanism of action of USPs in HCC not only helps to reveal the pathogenesis of HCC, but also provides a scientific basis for developing new diagnostic tools and treatment strategies. Future research should further explore the regulatory effect of USPs in HCC, in order to provide more effective means for the clinical treatment of HCC.
3.Therapeutic effect of traditional Chinese medicine in liver cancer by regulating tumor-associated macrophages and its mechanism
Yi TANG ; Guotai WANG ; Yuhan JIANG ; Chenyang WU
Journal of Clinical Hepatology 2025;41(6):1199-1206
Liver cancer has high prevalence and mortality rates around the world, and its development and progression are closely associated with the interaction between the tumor microenvironment and tumor-associated macrophages (TAMs). TAMs play a significant role in immune suppression, immune escape, cell proliferation, invasion, metastasis, and drug resistance in liver cancer. Traditional Chinese medicine (TCM), with its unique therapeutic concepts and methods, has shown great potential in regulating TAMs and improving the prognosis of liver cancer. This article reviews the role and molecular mechanisms of TCM in regulating TAMs for the treatment of liver cancer, discusses the key role of TAMs in the progression of liver cancer, and analyzes the impact of Chinese medicinal components on the recruitment, polarization, and activity of TAMs and the expression of related factors based on TCM theory. Studies have shown that TCM can regulate the polarization state of TAMs, promote the formation of M1-type antitumor macrophages, and inhibit the activity of M2-type tumor macrophages, thereby playing a role in inhibiting the proliferation of liver cancer cells, promoting apoptosis, inhibiting angiogenesis, and enhancing immune response. In addition, this article also summarizes the molecular targets and mechanisms of action of TCM monomers, compound prescriptions, and novel preparations in the treatment of liver cancer, such as inhibiting the secretion of cytokines by TAMs, regulating signaling pathways, and affecting metabolic pathways, in order to provide a scientific basis for the application of TCM in liver cancer treatment and offer new ideas for immunotherapy for liver cancer.